Ruiz P, Nassiri M, Viciana A L, Padmanabhan J, Streilein J W
Department of Pathology, University of Miami School of Medicine, FL 33101.
J Immunol. 1995 Jan 15;154(2):633-43.
Certain B10 background mouse strains are resistant to tolerance induction after neonatal inoculation of class I/II MHC-disparate F1 hybrid cells. Despite initial thymic deletion of alloreactive cells, the majority (95%) of these mice reacquire the capacity to reject donor allografts. These current studies examined thymi of adult B10.S (H-2S/H-2E-) mice that neonatally received (B10.S x B10.A)F1 cells, before and after rejection or acceptance of B10.A (H-2k/d/H-2E+) skin grafts. Alloreactive thymic V beta 11+ and V beta 5+ T cells were often reduced in the injected recipients preceding allograft challenge. In some mice a single B10.A skin graft generated an increase in these T cell populations concurrent with allograft rejection. Injected mice that accepted B10.A skin grafts (i.e., tolerant) or that rejected two sequential B10.A grafts often had a reduction of these T cells. Thymic memory cells (CD44high+) were present before transplant in injected mice and reduced in the tolerant mice. Donor chimeric cells were identified in the majority of injected mice before transplant and diminished after B10.A graft application. A greater proportion of chimeric cells coexpressed CD11b or B220 in the tolerant mice. Thus, neonatally injected B10.S mice resistant to tolerance induction reacquire immunocompetent thymic T cells bearing characteristics of memory T cells that could mediate graft rejection. Finally, the initial presentation of chimeric cells (e.g., macrophages) that may efficiently present class I Ags through H-2E likely increases the possibility of adult tolerance.
某些B10背景的小鼠品系在新生期接种I/II类主要组织相容性复合体(MHC)不相合的F1杂交细胞后对耐受诱导具有抗性。尽管最初同种反应性细胞在胸腺中被清除,但这些小鼠中的大多数(95%)重新获得了排斥供体同种异体移植物的能力。目前的这些研究检测了新生期接受(B10.S×B10.A)F1细胞的成年B10.S(H-2S/H-2E-)小鼠在接受或排斥B10.A(H-2k/d/H-2E+)皮肤移植物之前和之后的胸腺。在同种异体移植物攻击之前,注射受体中同种反应性胸腺Vβ11+和Vβ5+T细胞通常减少。在一些小鼠中,单个B10.A皮肤移植物在同种异体移植物排斥的同时使这些T细胞群体增加。接受B10.A皮肤移植物(即耐受)或排斥两个连续B10.A移植物的注射小鼠中,这些T细胞通常减少。胸腺记忆细胞(CD44高表达+)在注射小鼠移植前就存在,而在耐受小鼠中减少。在大多数注射小鼠移植前可识别出供体嵌合细胞,在应用B10.A移植物后减少。在耐受小鼠中,更大比例的嵌合细胞共表达CD11b或B220。因此,新生期注射的对耐受诱导具有抗性的B10.S小鼠重新获得了具有记忆T细胞特征的免疫活性胸腺T细胞,这些细胞可介导移植物排斥。最后,最初呈现的嵌合细胞(如巨噬细胞)可能通过H-2E有效地呈递I类抗原,这可能增加成年期耐受的可能性。